ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Recruiting · NCT05879913 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ASCVD Management Using CCTA in Prostate Cancer Patients on ADT | Arterial Occlusive Diseases, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, male reproductive organ cancer, male reproductive system disorder, myocardial ischemia, neoplasm, prostate cancer, prostate disorder, vascular disorder | Recruiting | Not applicable | 2026-10-05 | NCT05879913 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Indiana University | 297 |
| National Comprehensive Cancer Network | 27 |
| Pfizer | 431 |
| Sumitomo Pharma America, Inc. | 16 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | United States | 38 |
| IU Health Joe and Shelly Schwarz Cancer Center | Carmel | United States | 5 |
| Methodist Hospital | Indianapolis | United States | 4 |